Literature DB >> 21743278

Inhibitory effect of receptor for advanced glycation end products (RAGE) on the TGF-β-induced alveolar epithelial to mesenchymal transition.

Jeong Sup Song1, Chun Mi Kang, Chan Kwon Park, Hyung Kyu Yoon, Sook Young Lee, Joong Hyun Ahn, Hwa-Sik Moon.   

Abstract

Idiopathic pulmonary fibrosis (IPF) is a lethal parenchymal lung disease characterized by myofibroblast proliferation. Alveolar epithelial cells (AECs) are thought to produce myofibroblasts through the epithelial to mesenchymal transition (EMT). Receptor for advanced glycation end products (RAGE) is a member of the immunoglobulin superfamily of cell surface receptors whose activation is associated with renal fibrosis during diabetes and liver fibrosis. RAGE is expressed at low basal levels in most adult tissues except the lung. In this study, we evaluated the interaction of ligand advanced glycation end products (AGE) with RAGE during the epithelial to myofibroblast transition in rat AECs. Our results indicate that AGE inhibited the TGF-β-dependent alveolar EMT by increasing Smad7 expression, and that the effect was abolished by RAGE siRNA treatment. Thus, the induction of Smad7 by the AGE-RAGE interaction limits the development of pulmonary fibrosis by inhibiting TGF-β-dependent signaling in AECs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21743278      PMCID: PMC3203242          DOI: 10.3858/emm.2011.43.9.059

Source DB:  PubMed          Journal:  Exp Mol Med        ISSN: 1226-3613            Impact factor:   8.718


  42 in total

Review 1.  Advanced glycation end products and the kidney.

Authors:  Jürgen M Bohlender; Sybille Franke; Günter Stein; Gunter Wolf
Journal:  Am J Physiol Renal Physiol       Date:  2005-10

2.  Non-enzymatic glycation of bone collagen modifies osteoclastic activity and differentiation.

Authors:  Ulrich Valcourt; Blandine Merle; Evelyne Gineyts; Stéphanie Viguet-Carrin; Pierre D Delmas; Patrick Garnero
Journal:  J Biol Chem       Date:  2006-12-01       Impact factor: 5.157

Review 3.  GDP and AGE receptors: mechanisms of peritoneal damage.

Authors:  Vedat Schwenger
Journal:  Contrib Nephrol       Date:  2006       Impact factor: 1.580

4.  Controversial role of RAGE in the pathogenesis of idiopathic pulmonary fibrosis.

Authors:  E Bargagli; F Penza; N Bianchi; C Olivieri; D Bennett; A Prasse; P Rottoli
Journal:  Respir Physiol Neurobiol       Date:  2008-11-05       Impact factor: 1.931

5.  Hepatocyte growth factor inhibits epithelial to myofibroblast transition in lung cells via Smad7.

Authors:  Manasi N Shukla; Jane L Rose; Rabindranath Ray; Kira L Lathrop; Anuradha Ray; Prabir Ray
Journal:  Am J Respir Cell Mol Biol       Date:  2008-11-06       Impact factor: 6.914

6.  The role of the receptor for advanced glycation end-products in lung fibrosis.

Authors:  Mei He; Hiroshi Kubo; Kota Ishizawa; Ahmed E Hegab; Yasuhiko Yamamoto; Hiroshi Yamamoto; Mutsuo Yamaya
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-10-19       Impact factor: 5.464

7.  Loss of RAGE in pulmonary fibrosis: molecular relations to functional changes in pulmonary cell types.

Authors:  Markus A Queisser; Fotini M Kouri; Melanie Königshoff; Malgorzata Wygrecka; Uwe Schubert; Oliver Eickelberg; Klaus T Preissner
Journal:  Am J Respir Cell Mol Biol       Date:  2008-04-17       Impact factor: 6.914

8.  The role of high mobility group box1 in pulmonary fibrosis.

Authors:  Naoki Hamada; Takashige Maeyama; Tomonobu Kawaguchi; Michihiro Yoshimi; Jyutaro Fukumoto; Mizuho Yamada; Singo Yamada; Kazuyoshi Kuwano; Yoichi Nakanishi
Journal:  Am J Respir Cell Mol Biol       Date:  2008-04-25       Impact factor: 6.914

9.  A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis.

Authors:  Judson M Englert; Lana E Hanford; Naftali Kaminski; Jacob M Tobolewski; Roderick J Tan; Cheryl L Fattman; Lasse Ramsgaard; Thomas J Richards; Inna Loutaev; Peter P Nawroth; Michael Kasper; Angelika Bierhaus; Tim D Oury
Journal:  Am J Pathol       Date:  2008-02-02       Impact factor: 4.307

Review 10.  New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis: a potential role for stem cells in the lung parenchyma and implications for therapy.

Authors:  Mehrnaz Gharaee-Kermani; Margaret R Gyetko; Biao Hu; Sem H Phan
Journal:  Pharm Res       Date:  2007-03-01       Impact factor: 4.580

View more
  17 in total

Review 1.  EMT and interstitial lung disease: a mysterious relationship.

Authors:  Hidenori Kage; Zea Borok
Journal:  Curr Opin Pulm Med       Date:  2012-09       Impact factor: 3.155

2.  The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis.

Authors:  Kota Araki; Rie Kinoshita; Nahoko Tomonobu; Yuma Gohara; Shuta Tomida; Yuta Takahashi; Satoru Senoo; Akihiko Taniguchi; Junko Itano; Ken-Ichi Yamamoto; Hitoshi Murata; Ken Suzawa; Kazuhiko Shien; Hiromasa Yamamoto; Mikio Okazaki; Seiichiro Sugimoto; Kouichi Ichimura; Masahiro Nishibori; Nobuaki Miyahara; Shinichi Toyooka; Masakiyo Sakaguchi
Journal:  J Mol Med (Berl)       Date:  2020-11-09       Impact factor: 4.599

3.  Inhibition of TGF-β signaling and decreased apoptosis in IUGR-associated lung disease in rats.

Authors:  Miguel Angel Alejandre Alcázar; Rory E Morty; Lisa Lendzian; Christina Vohlen; Iris Oestreicher; Christian Plank; Holm Schneider; Jörg Dötsch
Journal:  PLoS One       Date:  2011-10-20       Impact factor: 3.240

4.  Toll-like receptor 4 on islet β cells senses expression changes in high-mobility group box 1 and contributes to the initiation of type 1 diabetes.

Authors:  Min Li; Lujun Song; Xiaodong Gao; Wenju Chang; Xinyu Qin
Journal:  Exp Mol Med       Date:  2012-04-30       Impact factor: 8.718

5.  AGEs in human lens capsule promote the TGFβ2-mediated EMT of lens epithelial cells: implications for age-associated fibrosis.

Authors:  Cibin T Raghavan; Mareen Smuda; Andrew J O Smith; Scott Howell; Dawn G Smith; Annapurna Singh; Pankaj Gupta; Marcus A Glomb; Ian Michael Wormstone; Ram H Nagaraj
Journal:  Aging Cell       Date:  2016-02-08       Impact factor: 9.304

6.  Spatially-Resolved Proteomics: Rapid Quantitative Analysis of Laser Capture Microdissected Alveolar Tissue Samples.

Authors:  Geremy Clair; Paul D Piehowski; Teodora Nicola; Joseph A Kitzmiller; Eric L Huang; Erika M Zink; Ryan L Sontag; Daniel J Orton; Ronald J Moore; James P Carson; Richard D Smith; Jeffrey A Whitsett; Richard A Corley; Namasivayam Ambalavanan; Charles Ansong
Journal:  Sci Rep       Date:  2016-12-22       Impact factor: 4.379

7.  Increased AGE-RAGE ratio in idiopathic pulmonary fibrosis.

Authors:  Carlos Machahua; Ana Montes-Worboys; Roger Llatjos; Ignacio Escobar; Jordi Dorca; Maria Molina-Molina; Vanesa Vicens-Zygmunt
Journal:  Respir Res       Date:  2016-11-05

8.  Rap1a Regulates Cardiac Fibroblast Contraction of 3D Diabetic Collagen Matrices by Increased Activation of the AGE/RAGE Cascade.

Authors:  Stephanie D Burr; James A Stewart
Journal:  Cells       Date:  2021-05-22       Impact factor: 6.600

9.  REC8 inhibits EMT by downregulating EGR1 in gastric cancer cells.

Authors:  Junhong Zhao; Lanlan Geng; Gaoyang Duan; Wanfu Xu; Yang Cheng; Zhiliang Huang; Zhenwen Zhou; Sitang Gong
Journal:  Oncol Rep       Date:  2018-02-01       Impact factor: 3.906

Review 10.  The perplexing role of RAGE in pulmonary fibrosis: causality or casualty?

Authors:  Timothy N Perkins; Tim D Oury
Journal:  Ther Adv Respir Dis       Date:  2021 Jan-Dec       Impact factor: 4.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.